Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor
Clinical trial NCT04023721 · TERMINATED
Trial details
- NCT number
- NCT04023721
- Sponsor
- F-star Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2020-07-16
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.